A NOVEL NQO1 SPECIFIC ANTI-TUMOR AGENT, SBSC-S3001, SELECTIVELY REGRESSES THE GROWTH OF TUMORS WITH HIGH NQO1 EXPRESSION

被引：0
|
作者：
Yun, Minhyuk [1 ]
Kim, Goo-Young [1 ]
Jo, Sang Woo [1 ]
In, Changhoon [1 ]
Moon, Gyu-Young [1 ]
Ko, In Seok [2 ]
Lee, Eun Ju [2 ]
Hong, Yong Rae [2 ]
Lee, Whee Seong [2 ]
Cho, Helen [1 ]
机构：
[1] Samyang Biopharmaceut Corp, Pangyo, South Korea
[2] Lmito Therapeut Inc, Pangyo, South Korea
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0734
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
734
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 46 条
  • [31] POTENTIAL OF A PHARMACOGENETIC-GUIDED ALGORITHM TO PREDICT OPTIMAL WARFARIN DOSING IN A HIGH-RISK HISPANIC PATIENT: ROLE OF A NOVEL NQO1☆2 POLYMORPHISM
    Hernandez-Suarez, D. F.
    Mirabal-Arroyo, J. E.
    Claudio, K.
    Torres, B. A.
    Lopez-Candales, A.
    Duconge, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 434 - 435
  • [32] Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel NQO1*2 Polymorphism
    Hernandez-Suarez, Dagmar F.
    Claudio-Campos, Karla
    Mirabal-Arroyo, Javier E.
    Torres-Hernandez, Bianca A.
    Lopez-Candales, Angel
    Melin, Kyle
    Duconge, Jorge
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2016, 4 (04):
  • [33] The Effect of a Sulforaphane and Maitake Mushroom Extract Combination on the Expression of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) and Glutathione S-Transferase theta-1 (GSTT1)
    Erwin, Sharis
    Ownby, Stacy
    Slider, Laxmi
    Cornblatt, Grace
    FASEB JOURNAL, 2015, 29
  • [34] Establishment of an isogenic human colon tumor model for NQO1 gene expression:: Application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo
    Sharp, SY
    Kelland, LR
    Valenti, MR
    Brunton, LA
    Hobbs, S
    Workman, P
    MOLECULAR PHARMACOLOGY, 2000, 58 (05) : 1146 - 1155
  • [35] 2-(Penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene, a Novel NQO1 Inducing Agent from Echinops grijs']jsii Hance
    Shi, Jing
    Zhang, Xiaoyu
    Jiang, Hai
    MOLECULES, 2010, 15 (08): : 5273 - 5281
  • [36] Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer
    B A Patrick
    A K Jaiswal
    Oncogene, 2012, 31 : 4362 - 4371
  • [37] Retraction Note: Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer
    B A Patrick
    A K Jaiswal
    Oncogene, 2017, 36 : 2920 - 2920
  • [38] Identification of the gene expression signature as a pharmacodynamic biomarker for a p53 context-specific anti-tumor agent Wee1 inhibitor
    Mizuarai, Shinji
    Yamanaka, Kazunori
    Itadani, Hiraku
    Nishibata, Toshihide
    Arai, Tsuyoshi
    Hirai, Hiroshi
    Kotani, Hidehito
    CANCER RESEARCH, 2009, 69
  • [39] CASC-578, a novel Chk1 inhibitor, is active as a single agent in solid tumors and displays synergistic anti-tumor activity in combination with Wee1 inhibition
    Vo, Alex
    Taylor, Janelle
    Rosler, Robert
    Piasecki, Julia
    Leviten, Dina
    Sierra, Teresa
    Dozier, Ashley
    Klucher, Kevin
    Boyle, Bob
    Boyce, Rich
    Peterson, Scott
    CANCER RESEARCH, 2017, 77
  • [40] RETRACTION: Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer (Retraction of Vol 31, Pg 4361, 2012)
    Patrick, B. A.
    Jaiswal, A. K.
    ONCOGENE, 2017, 36 (20) : 2920 - 2920
12345